Advances in the research between Fusobacterium nucleatum and colorectal cancer
10.3760/cma.j.issn115396-20210914-00363
- VernacularTitle:具核梭杆菌与结直肠癌的研究进展
- Author:
Haoran WANG
1
;
Yang LIU
;
Baiqiang LIN
;
Yunwei WEI
Author Information
1. 哈尔滨医科大学附属第一医院肿瘤腔镜外科，哈尔滨 150000
- Keywords:
Fusobacterium nucleatum;
Pathogenesis;
Early diagnosis;
Prognosis;
Colorectal diseases
- From:
International Journal of Surgery
2022;49(2):112-116
- CountryChina
- Language:Chinese
-
Abstract:
Colorectal cancer is a disease with high morbidity and mortality. Colorectal cancer has a poor prognosis, duing to the current limited treatment methods and can not achieve satisfactory treatment results. Therefore, how to diagnose colorectal cancer patients early and improve the prognosis has always been one of the problems in the medical and scientific research circles. As researchers gradually learn more about the intestinal flora including Fusobacterium nucleatum, the targeted treatment has been applied to the experimental research and clinical treatment of colorectal cancer. This paper reviews the research progress of Fusobacterium nucleatum on the pathogenesis, early diagnosis, prognosis and treatment of colorectal cancer in recent years.
